Gender Differences in Outcomes after Implantation of Left Ventricular Assist Devices.

[1]  James W Long,et al.  Two‐Year Outcomes with a Magnetically Levitated Cardiac Pump in Heart Failure , 2018, The New England journal of medicine.

[2]  Stefan Blankenberg,et al.  Gender differences and outcomes in left ventricular assist device support: The European Registry for Patients with Mechanical Circulatory Support. , 2018, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[3]  Harlan M. Krumholz,et al.  Adherence to Methodological Standards in Research Using the National Inpatient Sample , 2017, JAMA.

[4]  Robert L Kormos,et al.  Eighth annual INTERMACS report: Special focus on framing the impact of adverse events. , 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[5]  Gregory A. Ewald,et al.  A Fully Magnetically Levitated Circulatory Pump for Advanced Heart Failure , 2017, The New England journal of medicine.

[6]  Valluvan Jeevanandam,et al.  Intrapericardial Left Ventricular Assist Device for Advanced Heart Failure , 2017, The New England journal of medicine.

[7]  L. Lund,et al.  The Registry of the International Society for Heart and Lung Transplantation: Thirty-fourth Adult Heart Transplantation Report-2017; Focus Theme: Allograft ischemic time. , 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[8]  J. Butler,et al.  Improved Outcomes for Women on the Heart Transplant Wait List in the Modern Era. , 2015, Journal of cardiac failure.

[9]  S. Najjar.  Late bleeding and neurological sequelae after HeartMate II left ventricular assist device: risk factors from the prequel. , 2014, Journal of the American College of Cardiology.

[10]  Dean Y. Li,et al.  Bridge to Recovery: Understanding the Disconnect Between Clinical and Biological Outcomes , 2012, Circulation.

[11]  Pranav Loyalka,et al.  Use of an Intrapericardial, Continuous-Flow, Centrifugal Pump in Patients Awaiting Heart Transplantation , 2012, Circulation.

[12]  Eiran Z. Gorodeski,et al.  Should Women Receive Left Ventricular Assist Device Support?: Findings From INTERMACS , 2012, Circulation. Heart failure.

[13]  Magdi H. Yacoub,et al.  Reversal of Severe Heart Failure With a Continuous-Flow Left Ventricular Assist Device and Pharmacological Therapy: A Prospective Study , 2011, Circulation.

[14]  S. Russell,et al.  Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients. , 2010, Journal of the American College of Cardiology.

[15]  Nader Moazami,et al.  Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. , 2009, Journal of the American College of Cardiology.

[16]  S. Russell,et al.  Disparities in access to left ventricular assist device therapy. , 2009, The Journal of surgical research.

[17]  M. Oz,et al.  Effect of gender on bridging to transplantation and posttransplantation survival in patients with left ventricular assist devices. , 2004, The Journal of thoracic and cardiovascular surgery.

[18]  M. Oz,et al.  Multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system in patients awaiting heart transplantation. , 2001, The Journal of thoracic and cardiovascular surgery.

[19]  M C Oz,et al.  Long-term use of a left ventricular assist device for end-stage heart failure. , 2001, The New England journal of medicine.

[20]  G. Anderson,et al.  Out-of-pocket medical spending for care of chronic conditions. , 2001, Health affairs.